Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 8, 2012, Pages

  Hernandez, Laura L ^a   Gregerson, Karen A ^a   Horseman, Nelson D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

5 hydroxytryptamine; Lactation; Osteoblast; Prolactin; RANK ligand; RUNX2 CBFA1

Indexed keywords

CANCER GROWTH FACTOR; PARATHYROID HORMONE RELATED PROTEIN; PROLACTIN; SEROTONIN; SEROTONIN RECEPTOR; TRANSCRIPTION FACTOR RUNX2; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; BREAST CELL; BREAST EPITHELIUM; CANCER CELL; CONTROLLED STUDY; COW; EPITHELIUM CELL; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; SEROTONIN DEFICIENCY;

ANIMALS; BREAST NEOPLASMS; CATTLE; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM PROTEINS; PARATHYROID HORMONE-RELATED PROTEIN; RECEPTORS, SEROTONIN, 5-HT2; RNA, MESSENGER; SEROTONIN; SIGNAL TRANSDUCTION; TRYPTOPHAN HYDROXYLASE;

EID: 84859468589     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00666.2011     Document Type: Article

References (54)

1. Akech J, Wixted JJ, Bedard K, van der Deen M, Hussain S, Guise TA, van Wijnen AJ, Stein JL, Languino LR, Altieri DC, Pratap J, Keller E, Stein GS, Lian JB. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 29: 811-821, 2010.
2. Ardeshirpour L, Dann P, Adams DJ, Nelson T, VanHouten J, Horowitz MC, Wysolmerski JJ. Weaning triggers a decrease in receptor activator of nuclear factor-kappaB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice. Endocrinology 148: 3875-3886, 2007.
3. Bliziotes M. Update in serotonin and bone. J Clin Endocrinol Metab 95: 4124-4132, 2010.
4. Bostwick JR, Guthrie SK, Ellingrod VL. Antipsychotic-induced hyperprolactinemia. Pharmacotherapy 29: 1: 64-73, 2009.
5. Broadus AE, Mangin M, Ikeda K, Insogna KL, Weir EC, Burtis WJ, Stewart AF. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med 319: 556-563, 1988.
6. Caplan RH, Wickus GG, Sloane K, Silva PD. Serum parathyroid hormone-related protein levels during lactation. J Reprod Med 40: 216-218, 1995.
7. Clines GA, Guise TA. Molecular mechanisms and treatment of bone metastasis. Expert Rev Mol Med 10: e7, 2008.
8. DeMauro S, Wysolmerski J. Hypercalcemia in breast cancer: an echo of bone mobilization during lactation? J Mammary Gland Biol Neoplasia 10: 157-167, 2005.
9. Dobnig H, Kainer F, Stepan V, Winter R, Lipp R, Schaffer M, Kahr A, Nocnik S, Patterer G, Leb G. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80: 3699-3707, 1995.
10. Fiaschi-Taesch NM, Stewart AF. Minireview: parathyroid hormone-related protein as an intracrine factor-trafficking mechanisms and functional consequences. Endocrinology 144: 407-411, 2003.
11. Franceschi RT, Xiao G, Jiang D, Gopalakrishnan R, Yang S, Reith E. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 44, Suppl 1: 109-116, 2003.
12. Galli-Tsinopoulou A, Nousia-Arvanitakis S, Mitsiakos G, Karamouzis M, Dimitriadis A. Osteopenia in children and adolescents with hyperprolactinemia. J Pediatr Endocrinol Metab 13: 439-441, 2000.
13. Graham TR, Agrawal KC, Abdel-Mageed AB. Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells. Cancer Sci 101: 103-111, 2010.
14. Guo Y, Tiedemann K, Khalil JA, Russo C, Siegel PM, Komarova SV. Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation. Bone 43: 386-393, 2008.
15. Hedlund PB, Danielson PE, Thomas EA, Slanina K, Carson MJ, Sutcliffe JG. No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci USA 100: 1375-1380, 2003.
16. Hernandez LL, Limesand SW, Collier JL, Horseman ND, Collier RJ. The bovine mammary gland expresses multiple functional isoforms of serotonin receptors. J Endocrinol 203: 123-131, 2009.
17. Horst RL, Goff JP, Reinhardt TA. Adapting to the transition between gestation and lactation: Differences between rat, human and dairy cow. J Mammary Gland Biol Neoplasia 10: 141-156, 2005.
18. Hou Z, Bailey JP, Vomachka AJ, Matsuda M, Lockefeer JA, Horseman ND. Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) is induced by prolactin and suppressed by progesterone in mammary epithelium. 141: 4278-83, 2000.
19. Huang W, Yang S, Shao J, Li YP. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12: 3068-3092, 2007.
20. Inman CK, Shore P. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem 278: 48684-48689, 2003.
21. Jackson JC, Cross RJ, Walker RF, Markesbery WR, Brooks WH, Roszman TL. Influence of serotonin on the immune response. Immunology 54: 505-512, 1985.
22. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. The protein kinase C pathway plays a central role in the fibroblast growth factorstimulated expression and transactivation activity of Runx2. J Biol Chem 278: 319-326, 2003.
23. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of bone metastasis. Mol Cancer Ther 6: 2609-2617, 2007.
24. Klein M, Weryha G, Dousset B, Aubert V, Kaminsky P, Leclere J. [Physiological role of PTHrP]. Ann Endocrinol (Paris) 56: 193-204, 1995.
25. Komori T. Regulation of bone development and maintenance by Runx2. Front Biosci 13: 898-903, 2008.
26. Kovacs CS. Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 10: 105-118, 2005.
27. Kovacs CS, Chik CL. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab 80: 3036-3042, 1995.
28. Liao J, McCauley LK. Skeletal metastasis: established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev 25: 4: 559-571, 2006.
29. Luparello C, Santamaria F, Schilling T. Regulation of PTHrP and PTH/PTHrP receptor by extracellular Ca2 concentration and hormones in the breast cancer cell line 8701-BC. Biol Chem 381: 303-308, 2000.
30. Marshall AM, Nommsen-Rivers LA, Hernandez LL, Dewey KG, Chantry CJ, Gregerson KA, Horseman ND. Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution. J Clin Endocrinol Metab 95: 837-846, 2010.
31. Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey JP, Nieport KM, Walther DJ, Bader M, Horseman ND. Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell 6: 193-203, 2004.
32. McGrath MF. A novel system for mammary epithelial cell culture. J Dairy Sci 70: 1967-1980, 1987.
33. Misra M, Papakostas GI, Klibanski A. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 65: 1607-18; quiz 1590, 1760-1761, 2004.
34. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
35. Murray RD, Horsfield JE, McCormick WD, Williams HJ, Ward D. Historical and current perspectives on the treatment, control and pathogenesis of milk fever in dairy cattle. Vet Rec 163: 561-565, 2008.
36. Pai VP, Horseman ND. Regulation of epithelial turnover by serotonin through induction of cell loss. PLoS One: e17208, 2011.
37. Pai VP, Horseman ND. Biphasic regulation of mammary epithelialresistance by serotonin through activation of multiple pathways. J Biol Chem 283: 30901-30910, 2008.
38. Pai VP, Marshall AM, Hernandez LL, Buckley AR, Horseman ND. Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. Breast Cancer Res 11: R81, 2009.
39. Pai VP, Marshall AM. Intraluminal volume homeostasis: a common sertonergic mechanism among diverse epithelia. Commun Integr Biol 4: 532-537, 2011.
40. Pirola CJ, Wang HM, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL, Fagin JA. Angiotensin II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and post-transcriptional mechanisms. J Biol Chem 268: 1987-1994, 1993.
41. Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS, Lian JB. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25: 8581-8591, 2005.
42. Rankin W, Grill V, Martin TJ. Parathyroid hormone-related protein and hypercalcemia. Cancer 80 Suppl: 1564-1571, 1997.
43. Richard V, Rosol TJ, Foley J. PTHrP gene expression in cancer: do all paths lead to Ets? Crit Rev Eukaryot Gene Expr 15: 115-132, 2005.
44. Shibli-Rahhal A, Schlechte J. The effects of hyperprolactinemia on bone and fat. Pituitary 12: 96-104, 2009.
45. Shore P. A role for Runx2 in normal mammary gland and breast cancer bone metastasis. J Cell Biochem 96: 484-489, 2005.
46. Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Schork A, Crutchfield M, Stanczyk F, Russell-Aulet M. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276: 549-554, 1996.
47. Stewart AF. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton. J Bone Miner Res 17: 758-762, 2002.
48. Stiegler C, Leb G, Kleinert R, Warnkross H, Ramschak-Schwarzer S, Lipp R, Clarici G, Krejs GJ, Dobnig H. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J Bone Miner Res 10: 751-759, 1995.
49. Stull MA, Pai V, Vomachka AJ, Marshall AM, Jacob GA, Horseman ND. Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci USA 104: 16708-16713, 2007.
50. Thiede MA. Parathyroid hormone-related protein: a regulated calciummobilizing product of the mammary gland. J Dairy Sci 77: 1952-1963, 1994.
51. Thiede MA, Rodan GA. Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science 242: 278-280, 1988.
52. Uemura H, Yasui T, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Irahara M. Regulatory factors on parathyroid hormone-related peptide production by primary culture of lactating rat mammary gland. Horm Metab Res 37: 463-467, 2005.
53. VanHouten JN, Dann P, Stewart AF, Watson CJ, Pollak M, Karaplis AC, Wysolmerski JJ. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 112: 1429-1436, 2003.
54. Wysolmerski JJ. Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation. Ann NY Acad Sci 1192: 161-169, 2010002E